Rchr
J-GLOBAL ID:202201008903575427   Update date: Jan. 30, 2024

HASEGAWA MASANORI

ハセガワ マサノリ | HASEGAWA MASANORI
Affiliation and department:
Research theme for competitive and other funds  (3):
  • 2021 - 2024 Establishment of a novel therapy for renal cell carcinoma by induction of ferroptosis via lipo-quality modulation
  • 2019 - 2021 Establishment of a novel therapy for urothelial carcinoma by ferroptosis
  • 2017 - 2019 Targeting MUC1 improve the docetaxel resistance and increase the sensitivity for ferroptosis in castration resistant prostate cancer
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page